fashion -WSS

fashion

author：leisure time 2025-10-02 19:39:02 - browse：69168

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Chemotherapy shortages won’t get better under Biden’s latest plan

focus

Wikipedia

WSS

The woman behind the Dana Farber

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

10 states plan to sue EPA over standards for residential wood

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Patients' immediate access to test results puts radiologists in a bind

Roche to buy Carmot Therapeutics, developer of obesity drugs

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Patients' immediate access to test results puts radiologists in a bind

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA needs staff influx to meet gene therapy needs, Marks says

Apple is now the first public company to be valued at $3 trillion

Leukemia patients are helped by Syndax's new type of therapy

Heart attack and stroke risk calculators need revising

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Apple is now the first public company to be valued at $3 trillion

Spinal cord stimulation reduces pain in amputees, study finds

Wikipedia

STAT letters to the editor on burnt

STAT letters to the editor on burnt

In diabetes hearing, Sanders takes on a new foe: food makers

3 killed, 8 injured in late

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

A timeline of the missing Titanic tourist submersible

focus

focus

Wikipedia

hotspot